– Ajax Health raises $100M to close third medtech innovation, Ajax3 led by HealthQuest Capital with participation from Polaris Partners.
– Led by Duke Rohlen, Chairman and CEO, Ajax3 quickly follows the $100M raised in April 2019 for Ajax 2.
Ajax Health, Menlo Park, CA-based company investing in medical innovation, today announced it has raised $100 million to form its third Medtech innovation fund, Ajax3. The $100M in capital will target investments in companies in the areas of MedTech, healthcare services, and healthcare IT that focus on truly innovative approaches to addressing major issues in healthcare. The funding was led by HealthQuest Capital with participation from Polaris Partners. Ajax3 represents the company’s third fund and follows the $100 million previously raised in April 2019 for Ajax2.
Fueling Medical Innovation through Capital & Capabilities
AJAX Health accelerates medical innovation through capital and capabilities. Created in partnership with private equity leaders KKR and Aisling Capital in 2017, AJAX invests and takes an operating role in innovative medical companies that improve lives and bring speed, simplicity and cost efficiency to health care. Led by Duke Rohlen, Chairman and CEO and his trusted ecosystem of proven industry and operational experts. AJAX’s team has a proven track record of helping companies of all sizes, stages, and structures achieve their value-creation goals.
“We are excited about the progress of Ajax 2 companies and are thrilled to continue our partnership with Garheng and HealthQuest, as well as Polaris,” said Duke Rohlen, Chairman and CEO of Ajax Health. “The HealthQuest team has been integral to the momentum Ajax 2 has built to date and we look forward to continuing to leverage its expertise to identify and execute on new opportunities for Ajax 3.”
